Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
146.5 DKK | -1.99% | +0.65% | -16.77% |
Mar. 13 | Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults | MT |
Mar. 13 | Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.77% | 1.67B | |
+25.61% | 660B | |
+22.95% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.60% | 219B | |
-9.82% | 196B | |
+6.52% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- BAVA Stock
- News Bavarian Nordic A/S
- Bavarian Nordic's Denmark Vaccine Production Facility Gets Production OK from US, EU Regulators